Tomoyoshi Tachibana
Sendai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
ASO Author Reflections: Postoperative Carbohydrate Antigen 19-9 Levels Become a Reliable Biomarker for Establishing Intensity-Stratified Adjuvant Treatments in Pancreatic Ductal Adenocarcinoma.
Journal: Annals of surgical oncology
Published: October 06, 2023
Postoperative Carbohydrate Antigen 19-9 Level as a Good Indicator of Ineffective Response to the Currently Recommended S-1 Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma: A Single-Center, Retrospective Study.
Journal: Annals of surgical oncology
Published: June 13, 2023
Quantitative digital image analysis of somatostatin receptor 2 immunohistochemistry in pancreatic neuroendocrine tumors.
Journal: Medical molecular morphology
Published: April 08, 2021
Progesteron receptor expression in insulin producing cells of neuroendocrine neoplasms.
Journal: The Journal of steroid biochemistry and molecular biology
Published: October 06, 2019
A long-term survival case treated with conversion surgery following chemotherapy after diagnostic metastasectomy for pancreatic cancer with synchronous liver metastasis.
Journal: Surgical case reports
Published: October 03, 2017
High interlaboratory and interobserver agreement of somatostatin receptor immunohistochemical determination and correlation with response to somatostatin analogs.
Journal: Human pathology
Published: July 26, 2017
Progesterone arrested cell cycle progression through progesterone receptor isoform A in pancreatic neuroendocrine neoplasm.
Journal: The Journal of steroid biochemistry and molecular biology
Published: April 07, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026